SCHEMBL4359050

SCHEMBL4359050

Cc1cccc2nc(Cc3nc4cccc(C)c4[nH]3)[nH]c12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.44
EGFR P00533 2/20 0.43
ERBB2 P04626 1/20 0.43
KMT2A Q03164 2/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
KRAS P01116 1/20 0.41
CFB P00751 1/20 0.40
ALDH1A1 P00352 2/20 0.40
MEN1 O00255 1/20 0.40
THRB P10828 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
AR P10275 1/20 0.40
PARP1 P09874 1/20 0.40
HPGD P15428 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
DDAH1 O94760 1/20 0.39
PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6542837 0.90 GAA (0.60) GAAEGFRERBB2KMT2AMEN1
SCHEMBL4919557 0.87 DDAH1 (0.55) GAAEGFRERBB2KMT2ANPC1
SCHEMBL8328061 0.86 PKM (0.57) GAAEGFRERBB2KMT2ANPC1
SCHEMBL5204337 0.85 TDP1 (0.40) GAAEGFRERBB2KMT2ANPC1
SCHEMBL4062828 0.85 SMN1; SMN2 (0.40) GAAEGFRERBB2KMT2ANPC1
Hydrochloric Acid SCHEMBL8323740 0.84 PKM (0.59) GAAEGFRERBB2KMT2ANPC1
SCHEMBL6759265 0.84 MAPT (0.45) GAAKMT2ANPC1RAB9AALDH1A1
SCHEMBL1917212 0.84 ADORA3 (0.42) PARP1DDAH1
SCHEMBL6757131 0.82 NPC1 (0.37) GAAEGFRERBB2KMT2ANPC1
SCHEMBL28705698 0.82 HTR2A (0.44) GAAKMT2ANPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7498390-B2 Chromium complexes and their use in olefin polymerization EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2009-03-03 US disclosed
US-7498287-B2 Chromium complexes and their use in olefin polymerization EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2009-03-03 US disclosed
US-20080071090-A1 Chromium complexes and their use in olefin polymerization KACKER SMITA 2008-03-20 US disclosed
US-20080021181-A1 Chromium complexes and their use in olefin polymerization KACKER SMITA 2008-01-24 US disclosed
US-7297805-B2 Chromium complexes and their use in olefin polymerization EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2007-11-20 US disclosed
EP-1789425-A2 CHROMIUM COMPLEXES AND THEIR USE IN OLEFIN POLYMERIZATION ExxonMobil Research and Engineering Company (US) 2007-05-30 EP disclosed
WO-2006012327-A2 CHROMIUM COMPLEXES AND THEIR USE IN OLEFIN POLYMERIZATION EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2006-02-02 WO disclosed
US-20050288464-A1 Chromium complexes and their use in olefin polymerization EXXONMOBIL RESEARCH AND ENGINEERING COMPANY 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288464-A1 Chromium complexes and their use in olefin polymerization CBR3, CDYL, CCRL2 GAA 4618/4885EGFR 95/4885ERBB2 74/4885
US-20080071090-A1 Chromium complexes and their use in olefin polymerization CBR3, CDYL, CCRL2 GAA 4618/4885EGFR 95/4885ERBB2 74/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.